Vanguard Group’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Vanguard Group’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,088	Closed	-$104K	–	4093
2016 Q4	$104K	Buy	21,088 +5,289	+33%	+$23.3K	﹤0.01%	3968
2016 Q3	$67K	Buy	15,799 +8,981	+132%	+$40.2K	﹤0.01%	4009
2016 Q2	$28K	Hold	6,818	–	–	﹤0.01%	4107
2016 Q1	$22K	Buy	6,818 +1,888	+38%	+$6.06K	﹤0.01%	4120
2015 Q4	$18K	Buy	4,930 +2,600	+112%	+$12.9K	﹤0.01%	4175
2015 Q3	$16K	Sell	2,330 -10,872	-82%	-$99.7K	﹤0.01%	4178
2015 Q2	$208K	Buy	13,202 +850	+7%	+$17.4K	﹤0.01%	4040
2015 Q1	$280K	Buy	+12,352	New	+$245K	﹤0.01%	3944

Vanguard Group's WGBS Position: Q1 2017 in Review

Vanguard Group sold out of WaferGen Bio-systems, Inc. (WGBS) in Q1 2017, closing a stake of 21,088 shares — an estimated $104K sold.

Vanguard Group first reported a position in WGBS in Q1 2015 and held it in 8 quarters. The position peaked at $280K in Q1 2015. 0 funds tracked by Wall St. Rank hold WGBS as of Q1 2017.

Vanguard Group reported no remaining WaferGen Bio-systems, Inc. position as of Q1 2017 after selling out during the quarter.
Vanguard Group sold 21,088 WaferGen Bio-systems, Inc. shares in Q1 2017, an estimated $104K.
Vanguard Group first reported a position in WaferGen Bio-systems, Inc. in Q1 2015 and held it in 8 quarters.
Vanguard Group's WaferGen Bio-systems, Inc. position peaked at $280K in Q1 2015.
0 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q1 2017.

Based on Vanguard Group's 13F filing for Q1 2017, filed 12 May 2017.